FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
BioSpace12h
AbbVie’s Setback Gives BMS Commanding Lead in Schizophrenia Space
With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...
The Hindu26d
FDA approval for Cobenfy casts light on schizophrenia’s wickedness
On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...
Seeking Alpha23h
Bristol-Myers Squibb: Buy This Bargain Before It's Gone
However, in my estimation, starting in 2026, this financial metric will resume growth, including due to Cobenfy, which was ...
CBS News11d
FDA to pull common but ineffective cold medicine from market
The FDA's proposal comes more than a year after the agency's outside advisers voted against continued use of the ingredient, called oral phenylephrine, citing concerns with the initial data used ...
Pharmaceutical Technology12d
Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...
USA Today26d
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
Per the FDA, nitrosamine impurities "may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time." However, it added, "a person taking a ...
The Hill25d
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical
The Food and Drug Administration (FDA) issued a Class II recall of more than 7,100 bottles of the antidepressant duloxetine due to the possible presence of a carcinogen. Duloxetine belongs to a ...
Ars Technica11d
After decades, FDA finally moves to pull ineffective decongestant off shelves
Specifically, the FDA issued a proposed order to remove oral phenylephrine from the list of drugs that drugmakers can include in over-the-counter products—also known as the OTC monograph.
New York Post26d
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug have been recalled by the FDA because they were found to contain a suspected cancer-causing chemical. Over 7,100 bottles of ...
Yahoo10d
FDA proposes removing ineffective decongestant found in most cold medicine
(The Hill) — The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work. The move ...